Skip to content

Clinical trials

Withdrawn Phase 1/2 Stomach Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stomach Neoplasms Phase: Phase 1/2 Status: Withdrawn Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20151
20161
20201
20212
20222
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Artiva Biotherapeutics, Inc.1
Chongqing Precision Biotech Co., Ltd1
Eastern Cooperative Oncology Group1
Flame Biosciences1
Hokkaido Gastrointestinal Cancer Study Group1
NKGen Biotech, Inc.1
Rain Oncology Inc1
Tarus Therapeutics, Inc.1
Washington University School of Medicine1
Zhi Yang1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms10
Pancreatic Neoplasms6
Breast Neoplasms4
Colorectal Neoplasms4
Esophageal Neoplasms2
Liver Neoplasms2
Lung Neoplasms2
Neoplasm Metastasis2
Ovarian Neoplasms2
Recurrence2

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.